Cargando…
Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of Serotonin-Induced Reflex Apneas by Dronabinol in Sprague-Dawley Rats
The prevalence of obstructive sleep apnea (OSA) in Americans is 9% and increasing. Increased afferent vagal activation may predispose to OSA by reducing upper airway muscle activation/patency and disrupting respiratory rhythmogenesis. Vagal afferent neurons are inhibited by cannabinoid type 1 (CB(1)...
Autores principales: | Calik, Michael W., Carley, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211887/ https://www.ncbi.nlm.nih.gov/pubmed/25350456 http://dx.doi.org/10.1371/journal.pone.0111412 |
Ejemplares similares
-
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats
por: Calik, Michael W., et al.
Publicado: (2016) -
DMSO potentiates the suppressive effect of dronabinol on sleep apnea and REM sleep in rats
por: Calik, Michael W., et al.
Publicado: (2023) -
Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea
por: Prasad, Bharati, et al.
Publicado: (2013) -
Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
por: Parikh, Neha, et al.
Publicado: (2016) -
Hematoxicity of Amodiaquine in Sprague-Dawley Rats
por: Saka, W. A., et al.
Publicado: (2012)